Brasada Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-50
Closed -$2K 392
2018
Q2
$2K Hold
50
﹤0.01% 279
2018
Q1
$2K Hold
50
﹤0.01% 245
2017
Q4
$2K Buy
+50
New +$1.81K ﹤0.01% 263

Other funds holding RGEN

Brasada Capital Management's RGEN Position: Q3 2018 in Review

Brasada Capital Management sold out of Repligen (RGEN) in Q3 2018, closing a stake of 50 shares — an estimated $2K sold.

Brasada Capital Management first reported a position in RGEN in Q4 2017 and held it in 3 quarters. The position peaked at $2K in Q2 2018. 201 funds tracked by Wall St. Rank hold RGEN as of Q3 2018.

  • Brasada Capital Management reported no remaining Repligen position as of Q3 2018 after selling out during the quarter.
  • Brasada Capital Management sold 50 Repligen shares in Q3 2018, an estimated $2K.
  • Brasada Capital Management first reported a position in Repligen in Q4 2017 and held it in 3 quarters.
  • Brasada Capital Management's Repligen position peaked at $2K in Q2 2018.
  • 201 funds tracked by Wall St. Rank held Repligen as of Q3 2018.

Based on Brasada Capital Management's 13F filing for Q3 2018, filed 7 Nov 2018.